Background: Concerns over the association between suicidal behaviors and various medications have led to increasing efforts to assess suicidality in pharmacoepidemiologic studies. However, a number of methodological constraints (e.g., lack of data, poor measurement of suicidality constructs) have challenged these studies to date.
Objectives: 1) To share lessons learned and to increase awareness about challenges assessing suicidality in pharmacoepidemiologic studies; 2) To discuss strategies that may be employed to increase feasibility and effectiveness of suicidality assessments in future studies.
Description: The symposium will be of interest to individuals involved in drug safety research in general and suicidality assessments in particular.
